enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
13F holders, Q2 2024
Institutional positions in enGene Therapeutics Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −1 vs. Q1 2024
- Shares held
- 32.6M
- +951.1K (+3.0%) vs. Q1 2024
- Total value
- $307.1M
- −$228.9M (−42.7%) vs. Q1 2024
- New holders
- 6
- 8 more added
- Sold out
- 7
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $86.5M |
| Q1 2026 | 62 | $383.0M |
| Q4 2025 | 58 | $530.8M |
| Q3 2025 | 37 | $279.1M |
| Q2 2025 | 36 | $147.1M |
| Q1 2025 | 31 | $183.4M |
| Q4 2024 | 34 | $274.7M |
| Q3 2024 | 30 | $227.7M |
| Q2 2024 | 30 | $307.1M |
| Q1 2024 | 31 | $536.1M |
| Q4 2023 | 11 | $130.9M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FCPM III Services B.V. | 8,677,951 | $81.8M | 12.07% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,300,000 | $31.1M | 0.06% | +2,100,000+175.0% | Added |
| VR Adviser, LLC | 2,825,983 | $26.6M | 1.70% | +260,142+10.1% | Added |
| Blue Owl Capital Holdings LP | 2,449,827 | $23.1M | 6.43% | −11,523−0.5% | Reduced |
| BVF Inc | 2,251,037 | $21.2M | 0.59% | 00.0% | Unchanged |
| Deep Track Capital, LP | 2,250,000 | $21.2M | 0.63% | 00.0% | Unchanged |
| Logos Global Management LP | 1,200,000 | $11.3M | 1.30% | +400,000+50.0% | Added |
| Omega Fund Management, LLC | 1,076,357 | $10.2M | 7.52% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,000,000 | $9.43M | 0.55% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 1,000,000 | $9.04M | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 800,034 | $7.54M | 0.00% | +340.0% | Added |
| Perceptive Advisors LLC | 800,000 | $7.54M | 0.18% | −198,888−19.9% | Reduced |
| Soleus Capital Management, L.P. | 800,000 | $7.54M | 0.67% | 00.0% | Unchanged |
| Marshall Wace, LLP | 764,645 | $7.21M | 0.01% | −35,355−4.4% | Reduced |
| Boxer Capital, LLC | 727,900 | $6.86M | 0.36% | 00.0% | Unchanged |
| Vivo Capital, LLC | 678,705 | $6.40M | 0.59% | 00.0% | Unchanged |
| Citadel Advisors LLC | 613,292 | $5.78M | 0.01% | −190,886−23.7% | Reduced |
| Sr One Capital Management, LP | 500,000 | $4.71M | 1.48% | +500,000 | New |
| Ghost Tree Capital, LLC | 420,331 | $3.96M | 1.38% | +220,331+110.2% | Added |
| Silverarc Capital Management, LLC | 263,841 | $2.49M | 0.61% | +263,841 | New |
| Schonfeld Strategic Advisors LLC | 97,000 | $914.7K | 0.01% | +46,300+91.3% | Added |
| Point72 Asset Management, L.P. | 43,900 | $414.0K | 0.00% | −138,686−76.0% | Reduced |
| Geode Capital Management, LLC | 27,516 | $259.5K | 0.00% | +11,390+70.6% | Added |
| Verition Fund Management LLC | 14,843 | $140.0K | 0.00% | −47,579−76.2% | Reduced |
| Ameriprise Financial Inc | 12,524 | $118.1K | 0.00% | +12,524 | New |
| Royal Bank of Canada | 7,915 | $75.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,370 | $31.8K | 0.00% | +3,370 | New |
| Wells Fargo & Company | 972 | $9.17K | 0.00% | +972 | New |
| ADAR1 Capital Management, LLC | 600 | $5.66K | 0.00% | +600 | New |
| Morgan Stanley | 58 | $547 | 0.00% | +50+625.0% | Added |
| Commodore Capital LP | 0 | $0 | 0.00% | −1,250,000−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −120,289−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −65,225−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −9,757−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −289−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14−100.0% | Sold out |